A once-a-day pill could transform the lives of migraine sufferers after it was given the green light for NHS use. The National Institute for Health and Care Excellence (NICE) has recommended a ...
AbbVie’s Aquipta has become the first once-daily oral therapy for both chronic and ... as Scotland gave a green light to the drug in this indication last October, and makes the drug an option ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback